Evidence map›Paper›PMID 29636502›Full record

ArticleScientific reports2018

ACTH and PMX53 recover synaptic transcriptome alterations in a rat model of infantile spasms.

Dumitru A Iacobaş, Tamar Chachua, Sanda Iacobaş, Melissa J Benson, Karin Borges, Jana Velíšková, Libor Velíšek

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
4.2field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 31 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Hypothalamic-Pituitary-Adrenal Axis and Epilepsy.Journal of clinical neurology (Seoul, Korea) · 2024
    Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Powerful quantifiers for cancer transcriptomics.World journal of clinical oncology · 2020
    Review
  14. Review
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 2 countries.

Dumitru A IacobaşCenter for Computational Systems Biology, Prairie View AM University, Prairie View, TX, 77446, USA. daiacobas@pvamu.edu.
Tamar ChachuaNew York Medical College School of Medicine, Department of Cell Biology and Anatomy, Valhalla, NY, 10595, USA.
Sanda IacobaşNew York Medical College School of Medicine, Department of Pathology, Valhalla, NY, 10595, USA.
Melissa J BensonNew York Medical College School of Medicine, Department of Cell Biology and Anatomy, Valhalla, NY, 10595, USA.
Karin BorgesUniversity of Queensland, School of Biomedical Sciences, Brisbane, Australia.
Jana VelíškováNew York Medical College School of Medicine, Department of Cell Biology and Anatomy, Valhalla, NY, 10595, USA.
Libor VelíšekNew York Medical College School of Medicine, Department of Cell Biology and Anatomy, Valhalla, NY, 10595, USA.
New York Medical College · USUniversity of Queensland · AUPrairie View A&M University · US

Funding

Importance of Pannexin to Astrocyte and Neuronal ATPR01NS092786 · NINDS · NEW YORK MEDICAL COLLEGE · PI SCEMES, ELIANA, VELISKOVA, JANA · 2016 to 2019
$2.3M
Novel mechanism-based treatments for infantile spasmsRC4NS072966 · NINDS · NEW YORK MEDICAL COLLEGE · PI VELISEK, LIBOR · 2010 to 2010
$1.8M
NINDS NIH HHS R01 NS092786NINDS NIH HHS RC4 NS072966
6 · The paper itself

Abstract

We profiled the gene expression in the hypothalamic arcuate nuclei (ARC) of 20 male and 20 female rats to determine the infantile spasms (IS) related transcriptomic alteration of neurotransmission and recovery following two treatments. Rats were prenatally exposed to betamethasone or saline followed by repeated postnatal subjection to NMDA-triggered IS. Rats with spasms were treated with ACTH, PMX53 or saline. Since ACTH, the first line treatment for IS, has inconsistent efficacy and potential harsh side effects, PMX53, a potent complement C5ar1 antagonist, was suggested as a therapeutic alternative given its effects in other epilepsy models. Novel measures that consider all genes and are not affected by arbitrary cut-offs were used, in addition to standard statistical tests, to quantify regulation and recovery of glutamatergic, GABAergic, cholinergic, dopaminergic and serotonergic pathways. Although IS alters expression of ~30% of the ARC genes in both sexes the transcriptomic effects are 3× more severe in males than their female counterparts, as indicated by the Weighted Pathway Regulation measure. Both treatments significantly restored the ARC neurotransmission transcriptome to the non-IS condition with PMX53 performing slightly better, as measured by the Pathway Restoration Efficiency, suggesting these treatments may reduce autistic traits often associated with IS.

Indexed as

TranscriptomeAdrenocorticotropic HormoneAnimalsAnimals, NewbornComputational BiologyDisease Models, AnimalFemaleGene Expression ProfilingGene Expression RegulationGene Regulatory NetworksHumansInfant, NewbornMalePeptides, CyclicRatsSignal TransductionAcPhe(ornithine-Pro-cyclohexylamine-Trp-Arg)Adrenocorticotropic HormonePeptides, Cyclic

Identifiers

PMID29636502
PMCPMC5893534
OpenAlexW2797278679

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.